TIDES ASIA, Tokyo

Further information: TIDES Asia: Oligonucleotide & Peptide Therapeutics
Ana Isabel Jiménez and Pablo Lores will be representing Sylentis. Pablo will give two lectures:

“Phase-appropriate CMC considerations for next generation oligonucleotides”

“Lessons learned building an oligo CMC program for small company: doing more with less”